Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

Sugiyama Toru; Okamoto Aikou; Enomoto Takayuki; Hamano Tetsutaro; Aotani Eriko; Terao Yasuhisa; Suzuki Nao; Mikami Mikio; Yaegashi Nobuo; Kato Kiyoko; Yoshikawa Hiroyuki; Yokoyama Yoshihito; Tanabe Hiroshi; Nishino Koji; Nomura Hiroyuki; Kim Jae-Weon; Kim Byoung-Gie; Pignata Sandro; Alexandre Jerome; Green John; Isonishi Seiji; Terauchi Fumitoshi; Fujiwara Keiichi; Aoki Daisuke

首页> 外文期刊>Journal of Clinical Oncology >Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

【24h】

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

机译：伊立替康联合顺铂与紫杉醇联合卡铂作为卵巢透明细胞癌一线化疗的随机III期试验：JGOG3017 / GCIG试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2016年第24期|共10页
作者
Sugiyama Toru; Okamoto Aikou; Enomoto Takayuki; Hamano Tetsutaro; Aotani Eriko; Terao Yasuhisa; Suzuki Nao; Mikami Mikio; Yaegashi Nobuo; Kato Kiyoko; Yoshikawa Hiroyuki; Yokoyama Yoshihito; Tanabe Hiroshi; Nishino Koji; Nomura Hiroyuki; Kim Jae-Weon; Kim Byoung-Gie; Pignata Sandro; Alexandre Jerome; Green John; Isonishi Seiji; Terauchi Fumitoshi; Fujiwara Keiichi; Aoki Daisuke;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial [J] . Sugiyama Toru, Okamoto Aikou, Enomoto Takayuki, Journal of Clinical Oncology . 2016,第24期

机译：伊立替康联合顺铂与紫杉醇联合卡铂作为卵巢透明细胞癌一线化疗的随机III期试验：JGOG3017 / GCIG试验
3. Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II-IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016). [J] . K Harano, F Terauchi, N Katsumata, Annals of oncology: official journal of the European Society for Medical Oncology . 2014,第1期

机译：每周剂量密集的紫杉醇和卡铂与常规紫杉醇和卡铂作II-IV期卵巢癌一线治疗的随机III期试验的生活质量结果：日本妇科肿瘤学小组试验（JGOG3016）。
4. Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma. [J] . Vasey PA, Jayson GC, Gordon A, Journal of the National Cancer Institute . 2004,第22期

机译：多西他赛-卡铂与紫杉醇-卡铂作为卵巢癌一线化疗的III期随机试验。
5. Molecular Therapies in Hepatocellular Carcinoma beyond Sorafenib: Lessons from Failed Phase III Trials and Novel Targets [C] . Lipika Goyal, Andrew X. Zhu Gastrointestinal Cancers Symposium . 2014

机译：Sorafenib之外的肝细胞癌中的分子疗法：III期试验失败的课程和新型靶标
6. Bayesian Sequential Randomization Designs for Phase III Clinical Trials. [D] . Zhu, Han. 2016

机译：III期临床试验的贝叶斯顺序随机设计。
7. Randomized Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Advanced Non–Small-Cell Lung Cancer [O] . Corey J. Langer, Silvia Novello, Keunchil Park, -1

机译：一线非格单抗联合紫杉醇和卡铂与单独使用紫杉醇和卡铂治疗晚期非小细胞肺癌的随机III期试验
8. Phase III randomized trial of docetaxelcarboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma [O] . Paul A. Vasey, Gordon C. Jayson, Alan Gordon, 2004

机译：多西紫杉醇卡铂与紫杉醇 - 卡铂作为卵巢癌一线化疗的Ⅲ期随机试验

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅